Developmental Research Program
发展研究计划
基本信息
- 批准号:8607761
- 负责人:
- 金额:$ 10.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-17 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AwardBreastBreast Cancer PreventionBudgetsClinical TrialsDana-Farber Cancer InstituteDataDecision MakingDetectionDevelopmentDirect CostsEnsureFundingGoalsGrantInstitutionK-Series Research Career ProgramsLeadMonitorPeer ReviewPhaseProcessProgram DevelopmentPublicationsRequest for ApplicationsResearchResearch PersonnelResearch Project GrantsReview CommitteeWorkanticancer researchbaseimprovedmalignant breast neoplasmmemberprogramsresearch studyresponse
项目摘要
The Developmental Research Program (DRP) will fund small investigator-initiated projects with direct cost budgets of between $50,000-75,000. We are guaranteeing $200,000 per year for the DRP. Federal SPORE funds will make up $75,000 in the first year, with possible increases in subsequent years depending upon the availability of funds. Institutional commitment from the Dana-Farber Cancer Institute will provide $125,000 per year. Every effort to add additional philanthropic dollars to this amount will be made. In the previous DF/HCC Breast SPORE Grants, DRPs led to publications, grants, and clinical trials. One of the DRP awards from the previous SPORE has formed the basis of a large portion of Project 3 of this grant. The process for soliciting applications, awarding grants, monitoring research progress, and making decisions about ongoing funding are described in this section. The DRP has a transparent peer-reviewed selection process that incorporates defined criteria for funding decisions. The committee that oversees the process and selects the award recipients is the Developmental Research Program and Career Development Awards (DRP/CDP) Governance and Review Committee. The DRP will initiate a broad call for proposals to ensure the most promising early-phase research projects to receive meritorious funding, and investigators at all DF/HCC member institutions will be eligible to submit proposals. The DF/HCC has a large and talented investigator group to provide a wealth of applications from which to choose, and we anticipate a robust response to each and every request for applications that is announced.
发展研究计划(DRP)将资助小型企业发起的项目,直接成本预算在50,000 - 75,000美元之间。我们保证每年为DRP提供20万美元。联邦SPORE基金将在第一年提供75 000美元,随后几年可能会增加,这取决于资金的可用性。丹娜-法伯癌症研究所的机构承诺每年将提供125 000美元。将尽一切努力在这一数额上增加更多的慈善资金。在之前的DF/HCC乳腺孢子赠款中,DRP导致了出版物、赠款和临床试验。来自前一个SPORE的DRP奖项之一构成了该赠款项目3的大部分基础。本节介绍了申请、授予赠款、监测研究进展和决定持续资助的过程。DRP有一个透明的同行审查的选择过程,其中包含供资决定的明确标准。监督过程和选择获奖者的委员会是发展研究计划和职业发展奖(DRP/CDP)治理和审查委员会。DRP将发起广泛的提案征集,以确保最有前途的早期研究项目获得有价值的资助,DF/HCC成员机构的研究人员都有资格提交提案。DF/HCC拥有一个庞大而有才华的调查小组,可以提供丰富的应用程序供选择,我们预计将对宣布的每一个应用程序请求做出强有力的回应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC P WINER其他文献
ERIC P WINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC P WINER', 18)}}的其他基金
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
SPORE:丹娜—法伯癌症研究所/哈佛大学癌症中心 SPORE 在乳腺癌中的应用
- 批准号:
8607752 - 财政年份:2013
- 资助金额:
$ 10.7万 - 项目类别:
Administration, Advocacy, Planning and Communication Core
行政、宣传、规划和沟通核心
- 批准号:
8607757 - 财政年份:2013
- 资助金额:
$ 10.7万 - 项目类别:
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
SPORE:丹娜—法伯癌症研究所/哈佛大学癌症中心 SPORE 在乳腺癌中的应用
- 批准号:
8735888 - 财政年份:2013
- 资助金额:
$ 10.7万 - 项目类别:
Project 1 - Overcoming Breast Cancer Resistance to CDK4/6 Inhibition
项目 1 - 克服乳腺癌对 CDK4/6 抑制的耐药性
- 批准号:
10668342 - 财政年份:2013
- 资助金额:
$ 10.7万 - 项目类别:
相似海外基金
A novel strategy targeting TP63 for breast cancer prevention
一种针对 TP63 预防乳腺癌的新策略
- 批准号:
10608150 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
降低风险的药物可以改善儿童和青少年癌症幸存者的乳腺癌预防吗?
- 批准号:
10459788 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
A novel strategy targeting TP63 for breast cancer prevention
一种针对 TP63 预防乳腺癌的新策略
- 批准号:
10435255 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
Spatially informed interrogation of the high-risk breast for breast cancer prevention
对高风险乳房进行空间知情询问以预防乳腺癌
- 批准号:
473970 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
Fellowship Programs
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
降低风险的药物可以改善儿童和青少年癌症幸存者的乳腺癌预防吗?
- 批准号:
10675772 - 财政年份:2022
- 资助金额:
$ 10.7万 - 项目类别:
Proof-of-concept of time-restricted eating as a novel lifestyle intervention for breast cancer prevention
限时饮食作为预防乳腺癌的新型生活方式干预措施的概念验证
- 批准号:
460504 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
Operating Grants
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women
支持高危女性个性化乳腺癌预防和早期检测的模拟模型研究
- 批准号:
10201836 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women
支持高危女性个性化乳腺癌预防和早期检测的模拟模型研究
- 批准号:
10371141 - 财政年份:2021
- 资助金额:
$ 10.7万 - 项目类别:
PREVENT PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKER ENDPOINTS TASK ORDER: USE OF CARNOSIC ACID AND VIVOX40 FOR BREAST CANCER PREVENTION
预防临床前功效和中间生物标志物终点任务顺序:使用鼠尾草酸和 VIVOX40 预防乳腺癌
- 批准号:
10453429 - 财政年份:2020
- 资助金额:
$ 10.7万 - 项目类别:
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
生物标志物可提高非典型增生女性乳腺癌预防的针对性
- 批准号:
10542756 - 财政年份:2020
- 资助金额:
$ 10.7万 - 项目类别: